Clinical Trials Logo

Filter by:
NCT ID: NCT06020755 Not yet recruiting - Clinical trials for Gestational Trophoblastic Neoplasia

Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 7

TA7
Start date: September 2023
Phase: Phase 2
Study type: Interventional

The goal of this clinical trial is to evaluate the efficacy and safety of toripalimab plus actinomycin-D as fist-line treatment in patients with gestational trophoblastic neoplasia with FIGO score 7. The main questions it aims to answer are: - Whether toripalimab plus actinomycin-D as fist-line treatment can achieve a high complete response rate. - Whether an equally high cure rate can be achieved by multi-drug chemotherapy as second-line treatment in patients who have failed fist-line treatment with toripalimab plus actinomycin-D. Participants will receive toripalimab plus actinomycin-D. Treatment will be continued until disease progression, unacceptable toxicity, or withdrawal of consent. Treatment will be completed after 4 consolidation cycles.

NCT ID: NCT06020742 Enrolling by invitation - Infertility, Female Clinical Trials

Automitochondrial Transplantation Improves Live Birth in Elderly Patients With Low Prognosis After Repeated IVF Failure

ACTILB
Start date: February 9, 2023
Phase: N/A
Study type: Interventional

The goal to this clinical trial is to study the effectiveness and safety of automitochondrial transplantation of urine derived stem cells(USCs) in in elderly patients with low prognosis after repeated IVF failure. The main questions it aims to answer are: (1)test the effectiveness and safety of automitochondrial transplantation of urine derived stem cells (2) establish intracytoplasmic sperm injection(ICSI) mitochondrial transplantation platform Participants will be asked to:1)urine collections to further culture of autologous USCs 2)ovarian stimulation、trigger eggs、ICSI with autologous mitochondria 3)embryo transfer 4)accept pregnancy follow-up at given point

NCT ID: NCT06020690 Recruiting - Chronic Sinusitis Clinical Trials

A Clinical Study to Evaluate the Safety and Effectiveness of Novabel Bioabsorbable Steroid-releasing Stent for the Chronic Sinusitis

Start date: August 25, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about the safety and effectiveness of Novabel bioabsorbable steroid-releasing stent in chronic sinusitis. The main questions it aims to answer are: - The safety of this device for the chronic sinusitis - The effectiveness of this device for the chronic sinusitis Participants will be implanted bioabsorbable steroid-releasing stents after FESS surgery. Participants will be asked to be back to the clinic for follow-up 14 days, 30 days, 90 days, 180 days and 360 days after procedure. Researchers will compare test device and marketed device to see if the safety and effectiveness between these two devices are non-inferior.

NCT ID: NCT06020469 Recruiting - Anesthesia Clinical Trials

Comparative Effects of Ciprofol and Propofol on Pain Intensity on the First Day After Surgery: a Retrospective, Propensity Score Matched, Cohort Study

Start date: October 2023
Phase:
Study type: Observational

Data intelligence platform was widely used to facilitate the process of clinical research. However, a platform that integrates natural language processing (NLP) and machine learning (ML) algorithms has not been reported in perioperative medical management.

NCT ID: NCT06020430 Recruiting - Clinical trials for Non Small Cell Lung Cancer

Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy

Start date: February 8, 2024
Phase: N/A
Study type: Interventional

Radical radiotherapy is critical for locally advanced non small cell lung cancer(NSCLC ). Our previous sturdy indicated that patients who received induction immunotherapy and subsequent radiotherapy suffered higher proportion of pneumonitis.Grade 2 or more pneumonitis patients have worse prognosis. It is urged to optimize the radiotherapy dose and target volume for patients treated with immunotherapy and radiotherapy. According to retrospective and prospective studies, omitting CTV radiation is feasible for patients undergoing concurrent radio-chemotherapy for locally advanced NSCLC. It is postulated that omitting CTV radiation for patients responded to induction therapy with immunotherapy and chemotherapy will have less pneumonitis without sacrificing the local control rate. Omitting CTV may also retain better immune function which will facilitate the immunotherapy.

NCT ID: NCT06020365 Completed - Clinical trials for Fecal Microbiota Transplantation

Investigation of Fecal Microbiota Transplant in Chronic Intestinal Pseudo-obstruction Patients

FMT-CIP
Start date: January 1, 2018
Phase: N/A
Study type: Interventional

Chronic Intestinal Pseudo-Obstruction (CIPO) is a rare gastrointestinal disorder that primarily affects the movement of the intestines, leading to symptoms that resemble a true bowel obstruction but without a physical blockage. This condition is characterized by impaired motility of the gastrointestinal tract, which can result in severe symptoms and complications. In previous studies, the investigator found that sequential microbiota transplantation therapy can improve clinical symptoms of chronic pseudo-obstruction. Building on this foundation, the current study further investigates the effects of sequential interventions involving intestinal cleansing, small intestine bacterial treatment, fecal microbiota transplantation, and nutritional therapy on the short-term and long-term clinical symptom improvement in patients. Additionally, the investigator aim to elucidate the changes in gut microbiota phenotypes before and after treatment.

NCT ID: NCT06020352 Recruiting - NSCLC Clinical Trials

The Efficacy and Safety of KN046 Combined With Axitinib

Start date: August 25, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

Evaluation of the efficacy of KN046 combined with acitinib as a neoadjuvant therapy for resectable NSCLC through primary pathological response rate and surgical resection rate

NCT ID: NCT06020326 Recruiting - HFRS Clinical Trials

A Retrospective Cohort Study of HFRS

Start date: May 5, 2022
Phase:
Study type: Observational

The goal of this retrospective cohort study is to learn about the clinial characteristics of HFRS patients, explore the risk factors of the occurrence and death of HFRS, and build a risk prediction model for HFRS.

NCT ID: NCT06020287 Completed - Prostate Neoplasm Clinical Trials

The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior Approach

Start date: September 1, 2020
Phase:
Study type: Observational

The goal of this observational study was to compare the perioperative outcomes, postoperative urinary control rates and positive surgical margin (PSM) rates of the robot-assisted laparoscopic radical prostatectomy combined anterior and posterior approach (AP-RARP) with the Retzius-sparing approach (RS-RARP) and anterior approach (anterior-RARP) in the treatment of prostate cancer. The main question it aims to answer was: • The early therapeutic efficacy of the robot-assisted laparoscopic radical prostatectomy combined anterior and posterior approach Participants has been underwent: - AP-RARP - RS-RARP - anterior-RARP Researchers compared the three groups to see if AP-RARP combines the advantages of anterior and posterior RARP and is a feasible surgical option for the treatment of prostate cancer.

NCT ID: NCT06020144 Recruiting - Clinical trials for Rheumatoid Arthritis

A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs

TARA
Start date: November 15, 2023
Phase: Phase 3
Study type: Interventional

A randomized, double-blind, double-dummy, positive-controlled, phase 3 study to assess the safety and efficacy of TLL-018 in active rheumatoid arthritis subjects who had an inadequate response or intolerance to Biologic DMARDs.